Position in BIIB
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$193,165,196
-$1,866,385 QoQ
Shares Held
894,035
-16.0% QoQ
Ownership
0.606%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#26
of 1,037 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 19%
Shared 0%
None 81%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Derivatives in BIIB
reported options exposure · as of Sep 30, 2021CallValue
$3,395
CallShares
12
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $18,000,750,668 across 17 Drug Manufacturers - General names. BIIB ranks #10 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,379,627 | $4,053,626,340 | |
| 2 | JNJ |
Johnson & Johnson
|
15,661,323 | $3,977,506,192 | |
| 3 | ABBV |
AbbVie Inc.
|
10,772,949 | $2,710,904,874 | |
| 4 | AZN |
Astrazeneca PLC
|
12,640,672 | $2,396,924,218 | |
| 5 | MRK |
Merck & Co., Inc.
|
11,964,180 | $1,537,397,125 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
7,269,170 | $918,386,928 | |
| 7 | AMGN |
Amgen Inc
|
2,355,705 | $853,047,884 | |
| 8 | PFE |
Pfizer Inc
|
31,492,018 | $758,327,787 |
All Filings in BIIB
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $193,165,196 | 894,035 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $195,031,581 | 1,063,828 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $167,846,585 | 953,728 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $172,480,779 | 1,231,302 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $141,059,916 | 1,123,178 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $128,773,551 | 941,052 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $178,850,640 | 1,169,570 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $138,456,998 | 714,285 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $151,534,468 | 653,673 | Shares | Sole | 2025-06-12 | |
| 2024-03-31 | $228,020,310 | 1,057,461 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $307,907,830 | 1,189,890 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $240,685,234 | 936,482 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $343,296,371 | 1,205,183 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $456,455,191 | 1,641,748 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $512,610,483 | 1,851,114 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $428,113,941 | 1,603,423 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $339,947,373 | 1,666,899 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $303,241,039 | 1,439,891 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $375,767,494 | 1,566,220 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $3,395 | 12 | Call | Defined | 2021-11-04 | |
| 2021-09-30 | $390,945,582 | 1,381,482 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $490,039,217 | 1,415,194 | Shares | Defined | 2021-08-11 | |
| 2021-06-30 | $4,155 | 12 | Call | Defined | 2021-08-11 | |
| 2021-03-31 | $359,825,355 | 1,286,239 | Shares | Defined | 2021-05-13 | |
| 2021-03-31 | $3,357 | 12 | Call | Defined | 2021-05-13 | |
| 2020-12-31 | $245,268,417 | 1,001,668 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $334,688,772 | 1,179,811 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $270,424,012 | 1,010,742 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $338,110,234 | 1,068,684 | Shares | Defined | 2020-05-14 | |
| 2020-03-31 | $14,869 | 47 | Call | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||